Key Takeaways:Incubated and backed by L Catterton, Tally Health is a revolutionary consumer biotechnology company tackling the way we age.The acquisition, the largest in epigenetic age testing, brings together two category leaders to create a vertically integrated platform.The company is positioned to accelerate the development of next-generation diagnostics and interventions.TruDiagnostic parent Infinite Epigenetics acquires Dr. David Sinclair's company Tally Health to create the world’s largest epigenetic data platform.WHO: Tally Health, a consumer biotechnology company aimed at changing the way we age, was co-founded by Dr. David Sinclair, co-founder of Tally Health and Professor of Genetics at Harvard Medical School, and Whitney Casey, L Catterton partner, serial entrepreneur, and one of the world’s foremost experts on aging and human longevity. Tally Health develops proprietary, science-backed technology to improve healthspan and extend longevity at the cellular level. Individuals can learn their biological age, or TallyAge, with Tally's easy-to-use, at-home, noninvasive cheek swab test. The company uses a proprietary biological aging clock and a next-generation DNA analysis procedure to analyze genetic modifications that change throughout aging and reflect lifestyle habits.Infinite Epigenetics, through its subsidiary TruDiagnostic, is a leading epigenetic health data company and CLIA-certified laboratory specializing in epigenetic testing and research.